U.S. market Closed. Opens in 10 hours 20 minutes

ATOS | Atossa Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/A1.76K525.95K632.56K481.84K1.50KN/A
Cost of Revenue23.00K8.00K23.00K46.60K52.79KN/AN/AN/A132.41K340.66K495.46K65.63K97.19KN/A
Gross Profit-23.00K-8.00K-23.00K-46.60K-52.79KN/AN/AN/A-130.65K185.30K137.09K416.21K-95.69KN/A
Operating Expenses31.38M27.69M20.52M14.61M17.27M11.43M7.19M7.25M12.63M12.48M10.92M5.49M3.33MN/A
Selling, General & Admin14.04M12.61M11.31M8.00M10.62M7.22M4.86M6.48M10.27M9.90M9.82M5.49M3.33M894.36K
Research & Development17.33M15.08M9.21M6.61M6.65M4.21M2.33M770.43K2.36M2.58M1.11MN/AN/A120.00K
Other Operating ExpensesN/A-146.00K-85.00K50.80K25.65K29.30KN/AN/AN/AN/AN/AN/AN/A-1.01M
Operating Income-31.38M-27.69M-20.52M-14.61M-17.27M-11.43M-7.65M-7.25M-12.76M-12.29M-10.78M-5.07M-3.43M-1.08M
Other Expenses / Income1.28M731.00K-85.00K-3.22M25.65K29.30K-473.41K880.74K431.00-2.37M-65.00-10.82K-13.08K-8.68K
Before Tax Income-30.09M-26.96M-20.61M-17.83M-17.24M-11.40M-8.12M-6.37M-12.76M-14.66M-10.78M-5.08M-3.44M-1.09M
Income Tax ExpensesN/A-731.00K-213.56K3.27M-119.07K-29.30KN/AN/AN/AN/AN/AN/AN/A250.00
Net Income-30.09M-26.23M-20.61M-21.10M-17.24M-11.40M-8.12M-6.37M-15.76M-14.66M-10.78M-5.08M-3.44M-1.09M
Interest ExpensesN/A-8.00KN/AN/AN/AN/A192.82KN/AN/A15.77K360.0012.04K17.99K9.14K
Basic Shares Outstanding126.08M126.62M116.95M11.31M8.50M4.16M974.77K189.81K157.93K133.55K86.02K69.18K50.65K62.54K
Diluted Shares Outstanding126.08M126.62M116.95M11.31M8.50M4.16M974.77K189.81K157.93K133.55K86.02K69.18K50.65K62.54K
EBITDA-31.35M-27.69M-20.50M-11.29M-17.21M-11.39M-7.80M-6.95M-15.49M-14.08M-10.31M-4.94M-3.41M-1.08M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-880,983.85%-2,676.60%-1,630.11%-1,024.66%-227,243.60%0.00%
EBIT-30.09M-26.97M-20.82M-17.83M-17.36M-11.43M-7.93M-6.37M-15.76M-14.64M-10.78M-5.07M-3.42M-1.08M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-896,491.64%-2,783.92%-1,704.88%-1,051.76%-228,285.13%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙